Posts for Ticker ‘FAST’

Top 10 Pre-Market Analyst Calls (ABB, CAH, EV, FAST, GE, MMC, PETM, SPW, V)

These are not the only analyst calls being seen this Monday in pre-market hours, but these are the top calls that 247WallSt.com is focusing on so far this morning:

  • ABB (NYSE: ABB) cut to Equalweight From Overweight at Lehman.
  • Cardinal Health (NYSE: CAH) removed from Conviction Buy List but maintained Buy at Goldman Sachs.
  • Eaton Vance (NYSE: EV) Raised to Neutral from Underweight at JPMorgan.
  • Fastenal (NASDAQ: FAST) Cut to Neutral from Buy at Piper Jaffray.
  • General Electric (NYSE: GE) downgraded to Perform from Outperform at Oppenheimer; cut to Peer Perform from outperform at Bear Stearns.
  • Marsh & McLennan (NYSE: MMC) Raised to Outperform at KBW.
  • PETsMART (NASDAQ: PETM) raised to Buy from Neutral at Banc of America.
  • SPX Corp (NYSE: SPW) cut to Hold at Deutsche Bank.
  • Visa (NYSE: V) started as Outperform at KBW.

Jon C. Ogg
April 14, 2008

Posted on: April 14, 2008 – 6:11 am in Analyst Calls, , , , , , , , ,

Top 10 Pre-Market Analyst Calls (ARO, ABH, FAST, JCP, JWN, KERX, MHS, AMTR, SHOR, SPLS, VE)

These are some of the analyst calls that 247WallSt.com is focusing on in early pre-market trading this Monday morning:

  • Aeropostale (NYSE: ARO) Cut To Sell From Hold at Citigroup.
  • AbitibiBowater (NYSE: ABH) Raised to Market Perform at Raymond James.
  • Fastenal (NASDAQ: FAST) Started as Equalweight at Morgan Stanley.
  • JC Penney (NYSE: JCP) & Nordstom (NYSE: JWN) Raised to Buy at Goldman Sachs.
  • Keryx Biopharmaceuticals (NASDAQ: KERX) Cut to Neutral at JP Morgan.
  • Medco Health Solutions (NYSE: MHS) Raised to Buy at Goldman Sachs.
  • Omniture (NASDAQ: AMTR) Raised To Outperform at FBR.
  • ShoreTel (NASDAQ: SHOR) Cut to Neutral at Piper Jaffray.
  • Staples (NASDAQ: SPLS) cut to Neutral at Goldman Sachs.
  • Veolia Environnement (NYSE: VE) Raised to Buy at Citigroup.

Jon C. Ogg
March 10, 2008

Posted on: March 10, 2008 – 6:31 am in Analyst Calls, , , , , , , , , , ,

Pre-Market Stock News (July 12, 2007)

(AA) Alcoa trading up 6% after Rio Tinto gave a higher rival bid over Alcoa’s buyout offer for Alcan.
(AAON) AAON announced a 3 for 2 stock split.
(AL) Alcan gets a rival $38.1 Billion bid from Rio Tinto, above the ALCOA bid; shares up 11%.
(AMGN) Amgen and Daiichi Sankyo announced a collaboration and license agreement for the development and commercialization of denosumab in Japan.
(ARIA) Ariad Pharm and Merck entered into a collaboration to jointly develop and commercialize AP23573 for use in cancer.
(DNA) Genentech $0.78 EPS ($0.70 after items) and revenues were $3.0 Billion versus $0.71 & $2.85 Billion estimates; sees Fiscal 2007 EPS $2.85 to $2.95 versus $2.91 estimates.
(EROC) Eagle Rock is making 3 acquisitions totaling $420 million; sees 48% increase in "distributable cash flow."
(FAST) Fastenal announced a 1 million share buyback plan.
(GE) General Electric and Abbott Labs terminate sale of Abbott’s lab and diagnostics unit.
(GGBM) Gigabeam has regained compliance standards for NASDAQ listing.
(GTXI) GTX’s Phase III development of Acapodene review by an independent Data Safety Monitoring Board recommended that GTX continue clinical development.
(HAL) Halliburton’s board of directors approved its increased $2 Billion share buyback plan.
(IMCL) Imclone and Bristol-Myers Squibb said Erbitux Phase III study in first-line treatment of advanced lung cancer did not meet its primary endpoint of progression-free survival but secondary endpoints were statistically significant and favored the ERBITUX- containing arm.
(MAR) Marriott $0.57 EPS vs $0.53e; but Q3 looks under estimates.
(METH) Methode Electronics $0.33 EPS vs $0.17e; unsure if comparable as guidance range is in-line.
(MFLX) Multi-Fineline saw an unexpected sequential decline in Q3 revenue and now expects a loss.
(MOT) Motorola lowered guidance and sees no more profit from mobile division in 2007.
(NEM) Newmont Mining priced a $1 Billion convertible note offering.
(SPNC) Spectranetics received FDA approval for expanded labeling for TURBO elite to market its TURBO elite laser catheters to treat stenoses and occlusions within leg arteries.
(WMT) Wal-Mart June s-s-s +2.4% vs. 0.8% estimate; sees 1% to 2% July s-s-s growth; sees fiscal 2008 EPS within previous $0.75 to $0.79 guidance; shares indicated up 0.6%.
(WFMI) Whole Foods CEO Mackey has been touting his stock and attacking rival Wild oats for years on Yahoo! message boards.

Jon C. Ogg
July 12, 2007

Posted on: July 12, 2007 – 7:07 am in Pre-Market Activity, , , , , , , , , , , , , , , , , , , , , ,